Q1 2026 Holdings
Filed 2026-05-14 | 76 holdings | $697.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Maximus Inc(MMS) | COM | 577933104 | $49.3M | 768,825 | 7.1% |
| Waystar Hldg Corp(WAY) | COM | 946784105 | $39.6M | 1,642,236 | 5.7% |
| Icon PLC(ICLR) | SHS | G4705A100 | $33.9M | 306,358 | 4.9% |
| Cencora Inc(COR) | COM | 03073E105 | $31.7M | 100,894 | 4.5% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $31.1M | 370,045 | 4.5% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $29.9M | 5,382,965 | 4.3% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $27.2M | 674,759 | 3.9% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $26.8M | 421,615 | 3.8% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $23.2M | 605,439 | 3.3% |
| Celcuity Inc(CELC) | COM | 15102K100 | $22.1M | 193,843 | 3.2% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $21.3M | 385,879 | 3.1% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $20.4M | 265,543 | 2.9% |
| Abbott Laboratories(ABT) | COM | 002824100 | $19.2M | 186,574 | 2.7% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $16.3M | 1,847,850 | 2.3% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $15.1M | 135,800 | 2.2% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $13.4M | 1,498,620 | 1.9% |
| Haemonetics Corp Mass(HAE) | COM | 405024100 | $12.4M | 220,672 | 1.8% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $11.8M | 294,340 | 1.7% |
| Sanofi SA(SNY) | SPONSORED ADR | 80105N105 | $11.5M | 239,671 | 1.7% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $11.5M | 366,809 | 1.6% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $11.3M | 94,800 | 1.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $11.0M | 194,226 | 1.6% |
| Cross Ctry Healthcare Inc(CCRN) | COM | 227483104 | $10.3M | 1,098,393 | 1.5% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $10.3M | 1,969,839 | 1.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $10.1M | 209,093 | 1.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $9.8M | 1,163,926 | 1.4% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $9.5M | 173,506 | 1.4% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $9.3M | 721,785 | 1.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $9.1M | 249,887 | 1.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $8.5M | 268,986 | 1.2% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $8.3M | 1,506,525 | 1.2% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $8.2M | 968,597 | 1.2% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $8.0M | 1,922,887 | 1.1% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $6.7M | 965,000 | 1.0% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $6.5M | 132,496 | 0.9% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $6.5M | 331,730 | 0.9% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $6.3M | 86,083 | 0.9% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $5.9M | 359,011 | 0.8% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $5.7M | 62,613 | 0.8% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $5.5M | 720,036 | 0.8% |
| Organon & Co(OGN) | COMMON STOCK | 68622V106 | $5.2M | 865,908 | 0.7% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $4.5M | 1,078,965 | 0.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $4.2M | 65,203 | 0.6% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $3.8M | 3,076,580 | 0.5% |
| Immunome Inc(IMNM) | COM | 45257U108 | $3.6M | 165,110 | 0.5% |
| Integra Lifesciences Hldgs C(IART) | COM NEW | 457985208 | $3.6M | 383,140 | 0.5% |
| Savara Inc(SVRA) | COM | 805111101 | $3.4M | 613,888 | 0.5% |
| Centene Corp del(CNC)Put | COM | 15135B101 | $3.3M | 100,000 | 0.5% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $3.2M | 1,954,715 | 0.5% |
| Shoulder Innovations Inc(SI) | COMMON STOCK | 82537J108 | $3.1M | 210,641 | 0.4% |